TABLE 2.

Diagnosed population results (millions) (derived probability of diagnosis scenario)

	France	Germany	Italy	Spain	UK	Total
Higher‐prevalence scenario (% adult population)	3.6	4.1	4.4	3.9	4.1
NASH diagnosed as % of overall prevalence	5.6	24.2	3.7	1.9	20.3	12.7
F3‐F4 CC diagnosed as % of overall F3‐F4 CC prevalence	22.7	65.8	11.7	1.3	73.8	39.1
NASH diagnosed	0.1	0.7	0.1	0.03	0.4	1.3
F3‐F4 CC diagnosed	0.1	0.3	0.1	0.004	0.3	0.8
Lower‐prevalence scenario (n, % adult population)	2.2	1.4	1.7	2.2	2.2
NASH diagnosed as % of overall prevalence	5.7	24.2	3.8	1.9	20.3	11.8
F3‐F4 CC diagnosed as % of overall F3‐F4 CC prevalence	22.7	65.8	11.7	1.3	73.8	37.8
NASH diagnosed	0.1	0.2	0.03	0.02	0.2	0.6
F3‐F4 CC diagnosed	0.04	0.1	0.02	0.002	0.2	0.4

Numbers may not sum because of rounding.

Abbreviations: F3, fibrosis stage 3; F4 CC, fibrosis stage 4 compensated cirrhosis; NASH, non‐alcoholic steatohepatitis; UK, United Kingdom.